News | December 15, 2022
Kerala Ayurveda receives US patent for its herbal formulation
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
The approval further strengthens the Potassium Chloride franchise for the company.
Cyclophosphamide Capsules, 25 mg and 50 mg, have an estimated market size of US$ 8 million for twelve months ending Sep 2022 according to IQVIA.
The Group will continue to make proactive investments of its management resources in the life science business
Drospirenone Tablets (RLD Slynd) had estimated annual sales of US $141 million in the US
Subscribe To Our Newsletter & Stay Updated
